Polina E. Bellman
Hematology | Oncology
101 The City Drive South
Building 23
Orange, CA 92868
Building 23
Orange, CA 92868
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Bridging the Gap: Refining Myeloma Precursors and Their Risk of Progression Through Genomics.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 12, 2025
Impact of Stem Cell Mobilization with Chemotherapy Versus G-CSF Alone for Multiple Myeloma Patients with Suboptimal Response Before Autologous Stem Cell Transplant.
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 19, 2025
Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia.
Journal: British journal of haematology
Published: August 28, 2025
Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation.
Journal: Transfusion
Published: March 29, 2024
Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review.
Journal: Frontiers in oncology
Published: February 07, 2024
Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience.
Journal: Transplant immunology
Published: January 17, 2024
Adverse Hematological and Non-Hematological Events in Patients With Relapsed/Refractory Multiple Myeloma That Are Responsive to Daratumumab, Pomalidomide and Dexamethasone.
Journal: Journal of hematology
Published: December 27, 2022
Showing 1-7 of 7
Last Updated: 09/26/2026